FDA Investigator Michael L Chasey

Michael L Chasey has inspections in 7 countries as of 07 Apr 2023. Michael L Chasey has collaborated with a combinined 2592 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
22
Last Inspection Date:
07 Apr 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100007742
Country:
India, Germany, Finland, United Kingdom of Great Britain and Northern Ireland, China, Netherlands, Belgium
Co-Investigator(s):
Abby Lmozeke Baker, Ademola O Daramola, Anita Narula, PhD, Anna Lazar, Anthony C Warchut, Arthur T Ogdahl, Ashar P Parikh, Atul J Agrawal, Azza Talaat, Bijoy Panicker, Bonita S Chester, Burnell M Henry, Carl A Huffman, III, Carl Lee, Carol A Gripp, Charanjeet Jassal, Charisse K Green, Cheryl A Clausen, Christian D Lynch (CDL), Christina D Lynch, Christopher S Keating, Dawn C Olenjack, Denise M Digiulio, Dennis Cantellops Paite, Dipesh K Shah, Doan T Nguyen, PharmD, Dongping Dai, PhD, Dorothy W Lee, Dr. Robert C Horan, MD, Erika E Englund, PhD, Erika V Butler, Felix Maldonado, Freddy Ortiz, Freddy Ortiz Colon, Gene D Arcy, Gwyn G Dickinson, Helen B Ricalde, Jacqueline Mdiaz Albertini, James C Maclaughlin, James R Birkenstamm, James W Whitney, Jason K Morgan, Jawaid Hamid, Jennifer J Stone, Jessica Hankins, PhD, Jogy George, John D White, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose R Hernandez, Joseph R Haynes, Justin A Boyd, Katherine Szestypalow, Kevin P Foley, Kham Phommachanh, Larry K Austin, Larry K Hampton, Lata C Mathew, PhD, Laurimer Kuilan Torres, Libia M Lugo, Liming Zhang, Lindsey Brown, PhD, Lisa B Orr, Luella J Rossi, Luis A Dasta, Luis M Burgos Medero, Margaret M Annes, Marie F Morin, Marijo B Kambere, PhD, Marvin D Jones, Mary E Storch, Matthew B Casale, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael A Taylor, Michael R Goga, Michele L Forster, PhD, Michele L Glendenning, Miguel A Martinez, Mihaly S Ligmond, Mra Davism, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy M Espinal, Nebil A Oumer, Nicholas L Hunt, Nicole E Knowlton, Omotunde O Osunsanmi, Pal S Mayasandra, Pankaj H Amin, Parul M Patel, Patrick C Klotzbuecher, Paul A Bonneau, Paul Mouris, Paula A Trost, Peter E Baker, Pratik S Upadhyay, DDC, Qin Xu, Rajiv R Srivastava, Ramon A Hernandez, Randy L Self, Regina T Brown, Rita K Kabaso, Robert J Martin, Robert M Barbosa, Roger F Zabinski, Rose M Ashley, S Lori Brown, PhD MPH, Saied A Asbagh, Saleem A Akhtar, Samantha J Bradley, Sandra A Boyd, Sandra A Hughes, Sangeeta M Khurana, PhD, Satheesh Thomas, Scott B Laufenberg, Sherry G Bous, Sixto M Mercado Rios, Stephen J Koniers, Steven D Kehoe, Steven M Weinman, Susanna E Ford, Analyst, Susanne M Richardson, MSc RAC ELS, Temar Q Williams, Thomas E Friel, Thuy T Nguyen, LCDR, Unnee Ranjan, Valerie L Whipp, Viviana Matta, Wayne E Seifert, William A Warnick, William J Leonard, Xikui Chen (nmi), PhD, Yasamin Ameri, Youmin Wang, Yumi J Hiramine, Yvins Dezan, Zhongren Wu

Michael L Chasey's Documents

Publish Date Document Type Title
April, 2016 EIR Zhejiang Excel Pharmaceutical Company., Ltd. - EIR, 2016-04-01
June, 2013 FDA 483 USV Private Limited - Form 483, 2013-06-11
April, 2013 FDA 483 Canton Laboratories Pvt. Ltd. - Form 483, 2013-04-09
September, 2013 FDA 483 Glenmark Pharmaceuticals Limited - Form 483, 2013-09-25
September, 2019 EIR Almac Pharma Services Limited - EIR, 2019-09-06
May, 2013 EIR LUPIN LIMITED - EIR, 2013-05-17
June, 2013 EIR USV Private Limited - EIR, 2013-06-11
September, 2013 FDA 483 Wockhardt Limited - Form 483, 2013-09-13
October, 2013 EIR Smruthi Organics Limited - EIR, 2013-10-18
November, 2013 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2013-11-16
March, 2016 FDA 483 Boehringer Ingelheim Pharma GmbH and Co. KG - Form 483, 2016-03-08
March, 2013 EIR CIPLA LIMITED - EIR, 2013-03-01
March, 2016 EIR Boehringer Ingelheim Pharma GmbH and Co. KG - EIR, 2016-03-08
October, 2013 FDA 483 Smruthi Organics Limited - Form 483, 2013-10-18
February, 2013 EIR PCAS Finland Oy - EIR, 2013-02-08
September, 2013 EIR SYNGENE INTERNATIONAL LIMITED - EIR, 2013-09-18
November, 2013 EIR Sun Pharmaceutical Industries Limited - EIR, 2013-11-16
January, 2013 FDA 483 Fresenius Kabi Oncology Limited - Form 483, 2013-01-18
September, 2013 EIR VIRUPAKSHA ORGANICS LIMITED - EIR, 2013-09-26
September, 2013 EIR Glenmark Pharmaceuticals Limited - EIR, 2013-09-25
January, 2013 EIR Catalent Belgium SA - EIR, 2013-01-30
October, 2013 EIR Symeres Netherlands BV - EIR, 2013-10-16
May, 2013 FDA 483 Sai Life Sciences Limited - Form 483, 2013-05-08
January, 2013 EIR Fresenius Kabi Oncology Limited - EIR, 2013-01-18
October, 2013 FDA 483 Response MYLAN LABORATORIES LIMITED - Form 483R, 2013-11-07
May, 2013 EIR DISHMAN CARBOGEN AMCIS LIMITED - EIR, 2013-05-02
December, 2013 EIR Dr. Reddy's Laboratories (EU) Ltd. - EIR, 2013-12-20
October, 2013 EIR MYLAN LABORATORIES LIMITED - EIR, 2013-10-19
March, 2013 FDA 483 CIPLA LIMITED - Form 483, 2013-03-01
September, 2013 EIR Wockhardt Limited - EIR, 2013-09-13
September, 2016 FDA 483 Xinyu Pharmaceutical Co., Ltd. - Form 483, 2016-09-14
April, 2013 EIR Canton Laboratories Pvt. Ltd. - EIR, 2013-04-09
May, 2013 EIR Sai Life Sciences Limited - EIR, 2013-05-08
October, 2013 FDA 483 MYLAN LABORATORIES LIMITED - Form 483, 2013-10-19

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more